Understand the bias, discover the truth in your news. Get Started
News News
Bias Charts - New
Pricing & Services
Bias Meter
Tools
Gene therapy Follow
California applies to join groundbreaking initiative to expand access to lifesaving gene therapies for sickle cell disease
California
California applies to join groundbreaking initiative to expand access to lifesaving gene therapies for sickle cell disease
Village News
Apr 03, 2025

Somewhat Liberal

...
View Bias Rating
PANTHERx® Rare Introduces New Capabilities to Support Cell and Gene Therapies
PR Newswire
PANTHERx® Rare Introduces New Capabilities to Support Cell and Gene Therapies
The Times News
Apr 03, 2025

Somewhat Liberal

...
View Bias Rating
'Will it really work?': Young sickle cell patient among the first to start new gene therapy
Washington D.C.
'Will it really work?': Young sickle cell patient among the first to start new gene therapy
NBC News
Jan 18, 2025

Somewhat Liberal

...
View Bias Rating
Global Transfection Technologies Market Size To Worth USD 2.7 Billion By 2033 | CAGR Of 9.39% | Business Upturn
Gene
Global Transfection Technologies Market Size To Worth USD 2.7 Billion By 2033 | CAGR Of 9.39% | Business Upturn
Business Upturn
Aug 17, 2024

Center

...
View Bias Rating
Abeona Therapeutics Announces Favorable Medicare Reimbursement Decisions for Pz-cel
Patient
Abeona Therapeutics Announces Favorable Medicare Reimbursement Decisions for Pz-cel
wallstreet:online
Aug 13, 2024

Center

...
View Bias Rating
Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel
Gene therapy
Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel
Eagle-Tribune
Aug 13, 2024

Center

...
View Bias Rating
Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel - Abeona Therapeutics (NASDAQ:ABEO)
Gene therapy
Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel - Abeona Therapeutics (NASDAQ:ABEO)
Benzinga
Aug 13, 2024

Center

...
View Bias Rating
Duchenne muscular dystrophy gene therapy provides hope, concern
Antibody
Duchenne muscular dystrophy gene therapy provides hope, concern
Cronkite News
Jul 30, 2024

Center

...
View Bias Rating
Regenerative Medicine Market to Surpass USD 83.6 Billion by 2031 | Skyquest Technology
Stem cell
Regenerative Medicine Market to Surpass USD 83.6 Billion by 2031 | Skyquest Technology
Benzinga
Jul 12, 2024

Somewhat Liberal

...
View Bias Rating
InsightAce Analytic Pvt. Ltd: Cell & Gene Therapy Supply Chain Software Market Expected to Grow at a 13.9% CAGR from 2024-2031 | Latest Report by InsightAce Analytic
Logistics
InsightAce Analytic Pvt. Ltd: Cell & Gene Therapy Supply Chain Software Market Expected to Grow at a 13.9% CAGR from 2024-2031 | Latest Report ...
FinanzNachrichten.de
Jun 10, 2024

Somewhat Liberal

...
View Bias Rating
Nation & World
Sickle cell disease
Nation & World
Daily Journal
Nov 16, 2023

Center

...
View Bias Rating